Home » Newsletters » BioWorld Science

BioWorld Science

July 21, 2021

View Archived Issues

Bacteriophage endolysin LysECD7 shows promising antibiofilm activity

Celgene opens enrollment in phase I study of CC-90011 in metastatic CRPC

Biodegradable polymeric solid implants developed for long-acting HIV pre-exposure prophylaxis

Lethal autoinflammatory syndrome linked to loss-of-function C2orf69 gene variants

Dosing begins in phase I study of HLX-04-O in China

Medshine Discovery patents new compounds for NASH

Tecnimede-Sociedade Tecnico-Medicinal discloses compounds for tuberculosis

Wigen Biomedicine Technology presents GTPase KRAS mutant inhibitors

Latvian Institute of Organic Synthesis discloses tubulin polymerization inhibitors

First participants dosed in phase Ib/IIa FOCUSC9 study of WVE-004

NIMIUM and Paraza partner to develop G3PP activators to treat cardiometabolic diseases

Updated interim data from ongoing phase I/IIa study of OpRegen in dry AMD with GA

Lantern reports promising new preclinical data for LP-184 in pancreatic cancer

CA-125 is a diagnostic marker of tuberculosis in patients without HIV

Affinia and IOB collaborate to design novel CNS promoters for gene therapy

German clearance for phase I/IIa study of HDP-101 in multiple myeloma

Poor sleep quality in people with HIV is linked to lower CSF Abeta42 levels

Rab35-silencing as new strategy to impair HIV propagation

IL-12 and IL-18 are highly secreted in patients with HIV/TB coinfection

FDA clears IND for phase I/II trial of ExoFlo to treat post-acute COVID-19 syndrome

DSMB recommends continuation of phase II trial of ANVS-401 in Alzheimer's disease

All together now: Cure research plays big role at IAS 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...